Anthony Polverino
2019 - Zymeworks
In 2019, Anthony Polverino earned a total compensation of $1.3M as Executive Vice President, Early Development and Chief Scientific Officer at Zymeworks, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,000 |
|---|---|
| Option Awards | $758,019 |
| Salary | $400,000 |
| Other | $384 |
| Total | $1,336,403 |
Polverino received $758K in option awards, accounting for 57% of the total pay in 2019.
Polverino also received $178K in non-equity incentive plan, $400K in salary and $384 in other compensation.
Rankings
In 2019, Anthony Polverino's compensation ranked 7,896th out of 13,971 executives tracked by ExecPay. In other words, Polverino earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,896 out of 13,971 | 44th |
Division Manufacturing | 3,112 out of 5,701 | 45th |
Major group Chemicals And Allied Products | 1,177 out of 2,200 | 47th |
Industry group Drugs | 1,006 out of 1,886 | 47th |
Industry Pharmaceutical Preparations | 746 out of 1,398 | 47th |
Source: SEC filing on March 23, 2020.
Polverino's colleagues
We found four more compensation records of executives who worked with Anthony Polverino at Zymeworks in 2019.